SCA
INSP icon

Stonebridge Capital Advisors’s Inspire Medical Systems INSP Stock Holding History

Stonebridge Capital Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-165
Closed -$53.6K – 958
2023
Q2 		$53.6K Hold
165
– – 0.01% 352
2023
Q1 		$38.6K Hold
165
– – ﹤0.01% 399
2022
Q4 		$41.6K Hold
165
– – ﹤0.01% 378
2022
Q3 		$29K Hold
165
– – ﹤0.01% 412
2022
Q2 		$30K Buy
+165
New +$32.9K ﹤0.01% 429

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Stonebridge Capital Advisors's INSP Position: Q3 2023 in Review

Stonebridge Capital Advisors sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 165 shares — an estimated $53.6K sold.

Stonebridge Capital Advisors first reported a position in INSP in Q2 2022 and held it in 5 quarters. The position peaked at $53.6K in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Stonebridge Capital Advisors reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 165 Inspire Medical Systems shares in Q3 2023, an estimated $53.6K.
  • Stonebridge Capital Advisors first reported a position in Inspire Medical Systems in Q2 2022 and held it in 5 quarters.
  • Stonebridge Capital Advisors's Inspire Medical Systems position peaked at $53.6K in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.